They have a number of great prospects, but having the only drug targeting RhoA is so significant.
Easy to get fast tracked and approved with just a sniff of efficacy when there's no other option at all.
Timing ones buys on the stock market is so significant, and I think now is perfect.
There's always risk of course, but the down side is 1x at most, the upside 20x plus.
Ann: Ceasing to be a substantial holder, page-9
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
